Amit Khairnar
15PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 13, 2025
"DPP- 4 inhibitor alleviates gut-brain axis Parkinson's disease pathology" - can dipeptidyl peptidase 4 inhibitors be repurposed as disease-modifying drugs for body-first Parkinson's disease patients?Amit Khairnar, Irena Rektorova, Tiago F Outeiro
|Apr 07, 2025
Malondialdehyde Mediated Alpha-Synuclein Aggregation: A Plausible Etiology of Parkinson's Disease in Oxidative Stress.Harsh Thakkar, Sayan Chatterjee, Arvind Verma
|Mar 24, 2025
Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson's Disease Mouse Models.Ritu Soni, Vaishali Pankaj, Sudeep Roy
|Feb 21, 2025
Glycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson's Disease.Sayan Chatterjee, Arvind Verma, Harsh Thakkar
|Feb 20, 2025
Chronic DSS-Induced Colitis Exacerbates Parkinson's Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure.Nishant Sharma, Monika Sharma, Disha Thakkar
|Dec 19, 2024
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in Mice.Ritu Soni, Kirti Mathur, Hritik Rathod
Pageof 3
